Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Helical computed tomographic cholangiography versus endosonography for suspected bile duct stones: a prospective blinded study in non-jaundiced patients
1999
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
2015
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
2011
Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2014
Breast cancer
2019 Standout
Adding pharmacogenomics to the development of new marine-derived anticancer agents
2006
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma
2009
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
2014
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
2013 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Mechanism-based Pharmacokinetic/Pharmacodynamic Meta-analysis of Trabectedin (ET-743, Yondelis) Induced Neutropenia
2007
Results of laparoscopic vs. conventional appendectomy in complicated appendicitis
2001
Activation of the Nrf2/HO-1 signaling pathway by dimethyl fumarate ameliorates complete Freund's adjuvant-induced arthritis in rats
2021
Natural products: An evolving role in future drug discovery
2011 Standout
Ovarian cancer
2014 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Marine natural products
1990 Standout
FTO controls reversible m6Am RNA methylation during snRNA biogenesis
2019
Drug development from marine natural products
2008 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Trabectedin
2007
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Marine pharmacology in 2003–2004: Anti-tumour and cytotoxic compounds
2006
Phase II Study of Trabectedin in Pretreated Patients with Advanced Colorectal Cancer
2007
Detection of choledocholithiasis by EUS in acute pancreatitis: A prospective evaluation in 100 consecutive patients
2001
Soft-Tissue Sarcomas in Adults
2005 Standout
Lack of significant liver enzyme elevation and gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectomy: A population-based study
2011
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
2018
Bile duct stones and laparoscopic cholecystectomy: a decision analysis to assess the roles of intraoperative cholangiography, EUS, and ERCP
1999
Lung cancer: current therapies and new targeted treatments
2016 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone
2010
How to calculate the dose of chemotherapy
2002
Sarcopenia
2019 Standout
Oxidative Stress in Cancer
2020 Standout
Phase II study of weekly docetaxel in patients with metastatic breast cancer
2002
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
EUS for suspected choledocholithiasis: Do benefits outweigh costs? A prospective, controlled study
2003
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
2011
Natural compounds for cancer treatment and prevention
2009 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Practice Guidelines in Acute Pancreatitis
2006 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Reading, writing and erasing mRNA methylation
2019 Standout
Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft
2005
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy
2002
Cancer-related inflammation and treatment effectiveness
2014 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
2007
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
2017
ET-743: A Novel Agent with Activity in Soft Tissue Sarcomas
2005
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones
2015
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails
2005
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
Laparoscopic Appendectomy in Children: Evaluation of Different Techniques
2001
Laparoscopic versus open surgery for suspected appendicitis
2018 Standout
Adverse events associated with ERCP
2016 Standout
Marine natural products
2015 Standout
Trabectedin (Et-743): Evaluation of Its Use In Advanced Soft-Tissue Sarcoma
2007
Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
2010
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Aplidine: A Paradigm of how to Handle the Activity and Toxicity of a Novel Marine Anticancer Poison
2007
Kinase Inhibitors of Marine Origin
2013
Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743
2007
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
2001
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Dose translation from animal to human studies revisited
2007 Standout
Works of Jérôme Alexandre being referenced
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
2004
Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications
2017
CXCL12 expression by healthy and malignant ovarian epithelial cells
2011
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients
2011
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities
2005
Appendicectomie laparoscopique chez l'adulte
1998
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer
2011
Endoscopic Ultrasonography Immediately Prior to Laparoscopic Cholecystectomy: A Prospective Evaluation
1996
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
2017
Laparoscopic procedure for suspected appendicitis
1995
Update of randomized trials in recurrent disease
2011
Pegylated liposomal doxorubicin and carboplatin (C-PLD) versus paclitaxel and carboplatin (C-P) in platinum-sensitive ovarian cancer (OC) patients (pts): Treatment at recurrence and overall survival (OS) final analysis from CALYPSO phase III GCIG trial.
2011
Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients
2000
Dimethyl fumarate, a two‐edged drug: Current status and future directions
2019
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
2018